Led by a team of distinguished toxicology experts, TriApex was thrilled to take part in this prestigious meeting, engaging in ...
As of December 31, 2024, LAVA had cash, cash equivalents, and investments of $76.6 million, compared to cash, cash equivalents, and investments of $95.6 million as of December 31, 2023. The Company ...
LAKE ZURICH, IL, USA I March 27, 2025 I Fresenius announced that the Biologics License Application (BLA) for the denosumab biosimilars Conexxence® ...
CDI Labs Canada Inc., a leading provider of services for proteome-wide antibody profiling and target identification, today ...
March. 25, 2025, Keymed Biosciences Inc. (HKEX: 02162) announced its annual results of 2024, along with a corporate ...
Monoclonal antibodies lead biosimilar approvals because of their large market size, well-defined regulatory pathways, and ...
A new study offers hope in the fight against flesh-eating fungus infections. Researchers have discovered a promising antibody ...
Q4 2024 Earnings Call Transcript March 20, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.05, ...
SUZHOU, China I March 23, 2025 I CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer ...
Asian News International on MSN8d
Antibody-based therapy several notches closer to treat lethal mucormycosis: StudyMucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback